Multimodality vendor GE Healthcare and intravascular ultrasound (IVUS) developer Volcano of Rancho Cordova, CA, said that they have received U.S. Food and Drug Administration 510(k) clearance to integrate products.
The firms will combine Volcano's IVUS capabilities onto GE's Innova DR catheterization lab imaging system, according to Chalfont St. Giles, U.K.-based GE. The new imaging system will be marketed under the Innova IVUS name, GE said.
By AuntMinnie.com staff writers
August 24, 2006
Related Reading
GE touts ultrasound growth, August 22, 2006
Medrad, GE release eCoil, August 2, 2006
GE, PhotoCure extend partnership to U.S. market, July 31, 2006
GE signs Tulane, July 25, 2006
GE debuts wireless telemetry service, July 24, 2006
Copyright © 2006 AuntMinnie.com
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
